Latest

neuropharmacology

Featured Neuroscience Visual Neuroscience

·October 21, 2021·4 min read

Prozac Pegged as Potential First Treatment for a Leading Cause of Blindness

Fluoxetine, the antidepressant commonly known as Prozac, may be beneficial for the treatment of age-related macular degeneration. Researchers found Prozac significantly slowed the rate at which people over 50 developed AMD.

This shows the sensory neuron neurogenesis

Featured Neurology Neuroscience Open Neuroscience Articles

·October 19, 2021·5 min read

Drug Helps Sensory Neurons Regrow in the Mouse Central Nervous System

Fenofibrate, an FDA-approved drug commonly used to treat high cholesterol, activated support cells around sensory neurons in mouse models of spinal cord injury, helping them regrow twice as fast as a placebo.

This shows a woman rubbing her shoulder as though it's in pain

Featured Neuroscience Pain

·October 18, 2021·3 min read

Investigating the Link Between Antibiotic Use and Inflammatory Pain Reduction

Study reveals a causal mechanism for pain reduction may be due to an antibiotic-induced shift in the gut's amino acid concentrations.

This shows a child looking out of a window

Autism Featured Neuroscience

·October 14, 2021·5 min read

Hormone Widely Used as an Autism Treatment Shows No Benefit

Oxytocin therapy is ineffective at improving social skills in children on the autism spectrum.

Featured Neuroscience Psychology

·October 13, 2021·4 min read

A Potential End to Postpartum Depression

Neurosteroid replacement therapy may provide relief of symptoms for new mothers suffering from postpartum depression.

Featured Neurology Neuroscience

·October 11, 2021·3 min read

Water Pill May Be Viable to Test as Alzheimer’s Treatment

Bumetanide, an FDA-approved potent diuretic used to treat fluid retention caused by heart, kidney, and liver disease may lower the risk of developing Alzheimer's disease for those with a genetic predisposition.

Featured Neurology Neuroscience

·October 6, 2021·5 min read

Chemotherapy Drug Reverses Alzheimer’s Symptoms in Mice

Axitinib, a chemotherapy drug that inhibits the growth of new blood vessels in the brain, improved memory and cognition in mouse models of Alzheimer's disease.

Featured Neurology Neuroscience

·October 5, 2021·5 min read

The Mother of All Cannabinoids: Anti-seizure Compounds Discovered in Cannabis

Scientists have identified three acidic cannabinoids in cannabis that reduces seizure activity in mouse models of Dravet syndrome.

Featured Neuroscience

·October 4, 2021·5 min read

Intestinal Drug Shown to Boost Memory and Cognition

Prucalopride, a medication commonly prescribed to treat constipation, may help improve memory and cognition. People prescribed the drug for 6 days performed better in memory tests and had increased activity in brain areas associated with cognition.

Autism Featured Neuroscience

·October 3, 2021·3 min read

Acetaminophen Use During Pregnancy May Contribute to ADHD and Other Developmental Disorders

A 25-year study identifies a link between the use of acetaminophen during pregnancy and an increased risk of developmental disorders, including ADHD, autism, and decreased IQ in children.

Brain Cancer Featured Neurology Neuroscience Open Neuroscience Articles

·October 2, 2021·5 min read

New Treatment Combination Inhibits Glioblastoma Growth

A combination of approved and novel therapeutics improved survival rates and reduced both tumor volume and growth for those suffering from glioblastoma brain cancer.

Featured Neurology Neuroscience

·September 28, 2021·6 min read

Anti-Seizure Medication Improves Cognitive Function in Some Alzheimer’s Patients

Levetiracetam, an inexpensive drug commonly used in the treatment of epilepsy, improved memory, learning, and cognition for Alzheimer's patients who experience epilepsy activity in their brains.